Frontlight ResearchEarly access
Trial site
Olomouc
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- Chronic spontaneous urticaria1 trial
- Melanoma1 trial
- Multiple sclerosis1 trial
- Peripheral artery disease1 trial
- Prostate cancer1 trial
- Sarcoidosis1 trial
- Phase
- Phase 36 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Completed
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026